(Q34626941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

main subject

Cytomegalovirus

0 references

cytomegaloviral disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

3

Michael Green

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Carmen Ramil

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

279-290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11994033%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00128072-200204050-00001

10 December 2019

exact match

0 references

cites work

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200204050-00001

Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome

21 January 2018

1 reference

12 December 2020

Vaccination against cytomegalovirus, the changeling demon

1 reference

12 December 2020

Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation

1 reference

12 December 2020

Oral ganciclovir in pediatric transplant recipients: a pharmacokinetic study.

1 reference

12 December 2020

Nucleic acid sequence-based amplification

1 reference

12 December 2020

A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation

1 reference

12 December 2020

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

1 reference

12 December 2020

Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection

1 reference

12 December 2020

Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis

1 reference

12 December 2020

Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.

1 reference

12 December 2020

Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes

1 reference

12 December 2020

Randomized comparison of ganciclovir plus intravenous immune globulin (IVIG) with IVIG alone for prevention of primary cytomegalovirus disease in children receiving liver transplants

1 reference

12 December 2020

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

12 December 2020

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

1 reference

12 December 2020

Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management

1 reference

12 December 2020

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

1 reference

12 December 2020

Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patients

1 reference

12 December 2020

Preemptive Therapy in Immunocompromised Hosts

1 reference

12 December 2020

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

12 December 2020

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation

1 reference

12 December 2020

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation

1 reference

12 December 2020

Recurrent cytomegalovirus disease in solid-organ transplant recipients.

1 reference

12 December 2020

Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease

1 reference

12 December 2020

TRANSPLANTATION PNEUMONIA.

1 reference

12 December 2020

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

12 December 2020

Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group

1 reference

12 December 2020

Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis

1 reference

12 December 2020

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

12 December 2020

Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir

1 reference

12 December 2020

Cytomegalovirus disease and allograft loss after organ transplantation

1 reference

12 December 2020

Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants

1 reference

12 December 2020

Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects

1 reference

12 December 2020

Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction

1 reference

12 December 2020

Circulating immediate-early mRNA in patients with cytomegalovirus infections after solid organ transplantation

1 reference

12 December 2020

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Current status of intestinal transplantation in children

1 reference

12 December 2020

Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome

1 reference

12 December 2020

Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial

1 reference

12 December 2020

Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation

1 reference

12 December 2020

Cytomegalovirus infection and disease after liver transplantation

1 reference

12 December 2020

Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay.

1 reference

12 December 2020

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

1 reference

12 December 2020

Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

12 December 2020

Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

1 reference

12 December 2020

Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts

1 reference

12 December 2020

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

1 reference

12 December 2020

Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group

1 reference

12 December 2020

Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients

1 reference

12 December 2020

Prevention of cytomegalovirus disease in transplant recipients

1 reference

12 December 2020

Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients

1 reference

12 December 2020

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

12 December 2020

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

1 reference

12 December 2020

Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis

1 reference

12 December 2020

Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine

1 reference

12 December 2020

Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease

1 reference

12 December 2020

The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo

1 reference

12 December 2020

Prevention of cytomegalovirus infection after marrow transplantation.

1 reference

12 December 2020

Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction

1 reference

12 December 2020

Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study Group

1 reference

12 December 2020

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

12 December 2020

Meta-analysis of prophylaxis of CMV disease in solid organ transplantation: is Ganciclovir a superior agent to Acyclovir?

1 reference

12 December 2020

Susceptibility of human cytomegalovirus to two-drug combinations in vitro

1 reference

12 December 2020

Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.

1 reference

12 December 2020

Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients

1 reference

12 December 2020

Qualitative and semiquantitative polymerase chain reaction testing for cytomegalovirus DNA in serum allows prediction of CMV related disease in liver transplant recipients

1 reference

12 December 2020

Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay

1 reference

12 December 2020

Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response

1 reference

12 December 2020

Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

1 reference

12 December 2020

Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients

1 reference

12 December 2020

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children

1 reference

12 December 2020

Human cytomegalovirus glycoproteins

1 reference

12 December 2020

Cytomegalovirus infection after intestinal transplantation in children

1 reference

12 December 2020

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects

1 reference

12 December 2020

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients

1 reference

12 December 2020

A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipients

1 reference

12 December 2020

Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction

1 reference

12 December 2020

Cytomegalovirus prophylaxis strategies in high-risk transplantation

1 reference

12 December 2020

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

12 December 2020

Prophylactic oral ganciclovir after renal transplantation-dosing and pharmacokinetics.

1 reference

12 December 2020

Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients

1 reference

12 December 2020

Infection in organ-transplant recipients

1 reference

12 December 2020

Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation

1 reference

12 December 2020

Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes.

1 reference

12 December 2020

Prospective cytomegalovirus surveillance in paediatric renal transplant patients

1 reference

12 December 2020

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

12 December 2020

Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients.

1 reference

12 December 2020

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

1 reference

12 December 2020

Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes.

1 reference

12 December 2020

Impact of cytomegalovirus infection on organ transplant recipients

1 reference

12 December 2020

Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient.

1 reference

12 December 2020

The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?

1 reference

12 December 2020

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

1 reference

12 December 2020

Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.

1 reference

12 December 2020

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

12 December 2020

Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients

1 reference

12 December 2020

Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis

1 reference

12 December 2020

Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus

1 reference

12 December 2020

Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct)

1 reference

12 December 2020

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

12 December 2020

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

12 December 2020

A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood

1 reference

12 December 2020

Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group

1 reference

12 December 2020

Leukocyte-reduction to prevent transfusion-transmitted cytomegalovirus infections

1 reference

12 December 2020

Valaciclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluation

1 reference

12 December 2020

Reducing the Risk for Transfusion-transmitted Cytomegalovirus Infection

1 reference

12 December 2020

Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection.

1 reference

12 December 2020

Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation

1 reference

12 December 2020

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

1 reference

12 December 2020

Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens

1 reference

12 December 2020

Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients

1 reference

12 December 2020

Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: role of immunostaining, DNA hybridization and culture of hepatic tissue

1 reference

12 December 2020

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

12 December 2020

Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

12 December 2020

Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants

1 reference

12 December 2020